Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

561 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapy-related myeloid neoplasms.
Larson RA. Larson RA. Haematologica. 2009 Apr;94(4):454-9. doi: 10.3324/haematol.2008.005157. Haematologica. 2009. PMID: 19336749 Free PMC article. Review.
Larson explores the important question of whether the poor prognosis of these conditions reflects t-MN per se or, rather, associated findings such as complex cytogenetics that are also seen, although less frequently, in de novo myeloid neoplasms. ...
Larson explores the important question of whether the poor prognosis of these conditions reflects t-MN per se or, rather, associated
The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.
Larson RA, Day RS, Azarnia N, Bennett JM, Browman G, Goldberg J, Gottlieb A, Grunwald H, Miller K, Raza A, et al. Larson RA, et al. Br J Haematol. 1992 Oct;82(2):337-46. doi: 10.1111/j.1365-2141.1992.tb06427.x. Br J Haematol. 1992. PMID: 1419816 Clinical Trial.
Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
Geller RB, Myers S, Devine S, Larson RA, Williams SF, Park CL, O'Toole K, Chandler C, Topper RL. Geller RB, et al. Bone Marrow Transplant. 1992 Jan;9(1):41-7. Bone Marrow Transplant. 1992. PMID: 1543948 Clinical Trial.
Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults.
Geller RB, Larson RA. Geller RB, et al. Curr Opin Oncol. 1991 Feb;3(1):30-8. doi: 10.1097/00001622-199102000-00005. Curr Opin Oncol. 1991. PMID: 2043696 Review.
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Philip P, Diaz MO, Rowley JD. Super HJ, et al. Blood. 1993 Dec 15;82(12):3705-11. Blood. 1993. PMID: 8260707
Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
Spielberger RT, Dickstein JI, Le Beau MM, Larson RA, Daly KM, Vardiman JW, Golomb HM. Spielberger RT, et al. Br J Haematol. 1993 Mar;83(3):519-20. doi: 10.1111/j.1365-2141.1993.tb04680.x. Br J Haematol. 1993. PMID: 8485059 No abstract available.
Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient.
Spielberger RT, Falleroni MJ, Coene AJ, Larson RA. Spielberger RT, et al. Clin Infect Dis. 1993 Apr;16(4):528-30. doi: 10.1093/clind/16.4.528. Clin Infect Dis. 1993. PMID: 8513060
Therapy-related myeloid leukemia.
Thirman MJ, Larson RA. Thirman MJ, et al. Hematol Oncol Clin North Am. 1996 Apr;10(2):293-320. doi: 10.1016/s0889-8588(05)70340-3. Hematol Oncol Clin North Am. 1996. PMID: 8707757 Review.
561 results
Jump to page
Feedback